Trials / Completed
CompletedNCT01050348
To Investigate the Role of Upstream High Dose Statin in STEMI
A Double Blinded Randomized Placebo Controlled Study: To Investigate the Role of Upstream High Dose Statin Treatment in Patients With ST Segment Elevation Myocardial Infarction
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- The Western Pennsylvania Hospital · Academic / Other
- Sex
- All
- Age
- 25 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This is a double-blinded randomized placebo controlled trial investigating the role of upstream 80mg Atorvastastin-calcium in patients undergoing percutaneous intervention for acute STEMI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atorvastatin calcium | Eligible patients will receive 80mgs of atorvastatin orally upon admission to hospital prior to percutaneous intervention of the affected artery. Dose of post-procedural statin will be at the discretion of the cardiologist. |
| DRUG | Inactive Placebo | Eligible patients will receive a placebo orally upon admission to hospital prior to percutaneous intervention of the affected artery. |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2010-06-01
- Completion
- 2010-06-01
- First posted
- 2010-01-15
- Last updated
- 2018-10-05
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01050348. Inclusion in this directory is not an endorsement.